Skip to main content
. 2013 Oct 10;8(10):e76083. doi: 10.1371/journal.pone.0076083

Table 2. Principal maternal outcomes by level of proteinuria adjusted for age and ethnicity with risk ratios in comparison with PE 300 group (proteinuria 300- 499 mg/24 hours).

Preeclampsia Preeclampsia Chronic Hypertension Gestational Hypertension
300-499 mg/day ≥500 mg/day
N 60 161 615 110
Gestational age at diagnosis of preeclampsia, weeks 35.2 (3.8) 33.2 (4.1) - -
Severe gestational hypertension, N (%) 16 (26.7%) 58 (34.8%) 36 (5.9%) 11 (10.0%)
Diastolic blood pressure >110mmHg Risk ratio 1.30 (0.82 to 2.09) 0.22 (0.13 to 0.37)*** 0.38 (0.19 to 0.76)**
Maternal Intensive care unit admission, N (%) 1 (1.7%) 4 (2.5%) 3 (0.5%) 1 (0.9%)
Medication use after enrollment, N (%)
Parenteral anti-hypertensive use 2 (3.3%) 13 (8.1%) 8 (1.3%) 3 (2.7%)
Magnesium sulfate use 1 (1.7%) 28 (17.4%) 5 (0.8%) 1 (0.9%)
Risk Ratio 10.43 (1.45 to 75.01) *
Antenatal steroids 17 (28.3%) 64 (39.8%) 41 (6.7%) 6 (5.5%)
0.24 (0.14 to 0.39)*** 0.19 (0.08 to 0.46)***
Laboratory Investigations
N 52 149 369 80
Highest antenatal alanine aminotransferase (IU/L) (ALT) (Median, IQR) 17(13.25 to 29.75) 17 (11.5 to 26.5) 16 (12 to 22) * 15 (11 to 22)
Risk Ratio 0.78 (0.63 to 0.96)
ALT >40IU/L , N(%) 8 (15.4%) 18 (12.1%) 24 (6.5%) 8 (10.0%)
N 59 1160 452 99
Lowest antenatal platelets (x109/L) (Median, IQR) 210 (171 to 276) 224.5 (176 to 264) 241 (204 to 286)* 254 (218 to 284) **
Risk Ratio 1.10 (1.02 to 1.20) 1.15 (1.05 to 1.26)
Platelets <100 x109/L N(%) 1 (1.7%) 3 (1.9%) 3 (0.7%) 0
N 55 161 386 93
Highest antenatal Creatinine (µmol/L) (Median, IQR) 69 (62 to 77) 75 (66 to 87) ** 67 (60 to 74) 68 (61 to 75)
Risk Ratio 1.11 (1.04 to 1.19)
Creatinine >90µmol/l, N(%) 4 (7.1%) 30 (18.4%) 13 (3.4%) 7 (7.5%)

Data are given as mean (standard deviation) or number (percentage) together with risk ratios and 95% confidence intervals (CI).

Risk ratio, p in comparison with preeclampsia with proteinuria of 300 - 499 mg/24 hours; *P≤0.05; **P≤0.01; ***P≤0.001